Join to View Full Profile
330 Brookline AveBeth Israel Deaconess MedBoston, MA 02215
Are you Dr. Ko?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 4 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Yoo-Joung Ko, MD is an oncologist in Boston, Massachusetts.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1996 - 1999
Clinical Trials
- Single Agent Abraxane as Second Line Therapy in Bladder Cancer Start of enrollment: 2008 Mar 01
- SGI-110 in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
- Study of TRIFLURIDINE/TIPIRACIL in Previously Treated Cholangiocarcinoma Start of enrollment: 2019 Dec 11
Publications & Presentations
PubMed
- 4 citations2020 ASCO, 2023 NCCN, 2023 MASCC/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer pati...Samantha K F Kennedy, Shannon Goodall, Shing Fung Lee, Carlo DeAngelis, Allison Jocko
Supportive Care in Cancer. 2024-04-10 - Pan-Canadian consensus recommendations for GIST management in high- and low-throughput centres across Canada.J Robert Beecroft, Savtaj Brar, Xiaolan Feng, Trevor Hamilton, Cheng Han-Lee
Therapeutic Advances in Medical Oncology. 2024-01-01 - 55 citationsThe CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarc...Daniel J Renouf, Jonathan M Loree, Jennifer J Knox, James T Topham, Petr Kavan
Nature Communications. 2022-08-26
Professional Memberships
- Member
